AlloMap
Links shared publicly online about this topic
XDx AlloMap Gets CE Mark in Europe | IVD Technology
ivdtechnology.com — “XDx Inc. announced that its AlloMap Molecular Expression Test has been CE marked in the European Union (EU) under the IVD Directive. The CE mark certifies that a product has met EU health, safety and environmental requirements, which ensure consumer safety. AlloMap is a noninvasive FDA-cleared test that has been on the market in the United States since January 2005.” View full resource at ivdtechnology.com
Most Recently Shared on April 13, 2011 at 5:46 pm By:
IVD Technology Health Magazine
XDx AlloMap Gets CE Mark in Europe http://tinyurl.com/67wouey
XDx's AlloMap May Reduce Post-Transplant Biopsies - NYTimes.com
nytimes.com — “A study found that a test that analyzes genetic activity may help avoid invasive approaches to detect rejection of transplanted hearts.” View full resource at nytimes.com
Most Recently Shared on April 22, 2010 at 5:29 pm By:
HealthTrendster Health Executive
XDx’s AlloMap May Reduce Post-Transplant Biopsies - A study found that a test that analyzes genetic activity may he... http://ow.ly/178UJL
XDx's AlloMap May Reduce Post-Transplant Biopsies - NYTimes.com
nytimes.com — “A study found that a test that analyzes genetic activity may help avoid invasive approaches to detect rejection of transplanted hearts.” View full resource at nytimes.com
Most Recently Shared on April 22, 2010 at 2:29 pm By:
XDx’s AlloMap May Reduce Post-Transplant Biopsies http://nyti.ms/atOaDg
NYT: XDx's AlloMap May Reduce Post-
mobile.nytimes.com — “A study found that a test that analyzes genetic activity may help avoid invasive approaches to detect rejection of transplanted hearts.” View full resource at mobile.nytimes.com
Most Recently Shared on April 22, 2010 at 5:54 pm By:
Scott Hensley Health Organization
Here's link to story behind inscrutable NYT hed: : http://mobile.nytimes.com/article?a=583298&f=19
XDx's AlloMap May Reduce Post-Transplant Biopsies - NYTimes.com
nytimes.com — “A study found that a test that analyzes genetic activity may help avoid invasive approaches to detect rejection of transplanted hearts.” View full resource at nytimes.com
Most Recently Shared on April 22, 2010 at 4:07 pm By:
'Paradigm shift'?: Blood test could reduce invasive, uncomfortable biopsies after heart transplants (via NY Times). http://budurl.com/bqq7
XDx's AlloMap May Reduce Post-Transplant Biopsies - NYTimes.com
nytimes.com — “A study found that a test that analyzes genetic activity may help avoid invasive approaches to detect rejection of transplanted hearts.” View full resource at nytimes.com
Most Recently Shared on April 22, 2010 at 4:34 pm By:
Blood test for rejection gene markers may preclude need for cardiac biopsy in heart transplant patients http://nyti.ms/aIUsw7
Test may let transplant patients skip biopsies | Reuters
reuters.com — “CHICAGO (Reuters) - A gene-based blood test worked as well as a surgical procedure used to check for signs of rejection in patients with heart transplants, U.S. researchers said on Thursday. They said” View full resource at reuters.com
Most Recently Shared on April 22, 2010 at 10:00 pm By:
Hisham Rana, MD Doctor and Physician
Study: Blood test called AlloMap may let heart transplant patients skip frequent biopsies http://bit.ly/bxijSK - #health
Test may let transplant patients skip biopsies | Reuters
reuters.com — “CHICAGO (Reuters) - A gene-based blood test worked as well as a surgical procedure used to check for signs of rejection in patients with heart transplants, U.S. researchers said on Thursday. They said” View full resource at reuters.com
Most Recently Shared on April 22, 2010 at 4:26 pm By:
HealthIT Policy Health News and Health IT
Test may let transplant patients skip biopsies: CHICAGO (Reuters) - A gene-based blood test worked as well as a su... http://bit.ly/aeQIrg
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
IVD Technology
The official tweet feed from IVD Technology magazine. Published by Canon Communications.
-
HealthTrendster
Sharing health news and trends.
-
NYTimes Health
Health News from NYTimes.com/Health
Advertisement
